BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24333759)

  • 1. Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?
    Baecklund E; Smedby KE; Sutton LA; Askling J; Rosenquist R
    Semin Cancer Biol; 2014 Feb; 24():61-70. PubMed ID: 24333759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
    Smedby KE; Baecklund E; Askling J
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?
    Yadlapati S; Efthimiou P
    Biomed Res Int; 2016; 2016():8631061. PubMed ID: 27429984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type.
    Thieblemont C; Bertoni F; Copie-Bergman C; Ferreri AJ; Ponzoni M
    Semin Cancer Biol; 2014 Feb; 24():33-42. PubMed ID: 24333758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
    Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
    J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.
    Smedby KE; Askling J; Mariette X; Baecklund E
    J Intern Med; 2008 Dec; 264(6):514-27. PubMed ID: 19017176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5 positivity on peripheral blood B lymphocytes in patients with primary Sjögren's syndrome.
    Zeher M; Surányi P; Szegedi G
    Allergol Immunopathol (Madr); 1990; 18(2):75-8. PubMed ID: 1695475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
    Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
    Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoproliferative disorders in Sjögren's syndrome.
    Masaki Y; Sugai S
    Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach.
    De Vita S; De Marchi G; Sacco S; Gremese E; Fabris M; Ferraccioli G
    Blood Cells Mol Dis; 2001; 27(4):757-66. PubMed ID: 11778660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell lymphomagenesis in autoimmune diseases: the missing links.
    Dias C; Martins J; Dias G; Faria T; Brazão LR
    Discov Med; 2012 Jun; 13(73):417-24. PubMed ID: 22742647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marginal zone lymphoma: Associated autoimmunity and auto-immune disorders.
    Teixeira Mendes LS; Wotherspoon A
    Best Pract Res Clin Haematol; 2017; 30(1-2):65-76. PubMed ID: 28288719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
    Theander E; Jacobsson LT
    Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual association between lymphoma and autoimmunity.
    Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
    Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
    Tzioufas AG; Voulgarelis M
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sjögren syndrome and pseudolymphoma.
    Talal N
    Hosp Pract (Off Ed); 1988 Sep; 23(9A):71-5, 78-80. PubMed ID: 3138270
    [No Abstract]   [Full Text] [Related]  

  • 17. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management.
    Nocturne G; Mariette X
    Br J Haematol; 2015 Feb; 168(3):317-27. PubMed ID: 25316606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
    J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis.
    Voulgarelis M; Moutsopoulos HM
    Rheum Dis Clin North Am; 2008 Nov; 34(4):921-33, viii. PubMed ID: 18984412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
    Tomás S; Coll J; Reth P; Corominas JM
    Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.